论文部分内容阅读
Objective: Trastuzumab has been shown to medicate antibody dependent cell mediated cytotoxicity (ADCC) and inhibit HER-2.Associated Natural Killer (NK) cell with ADCC effect in metastatic breast cancer remains unknown.